Replimune Group REPL Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

FMC CorporationFMC

$1.9M-80.4%

APO

Apogee EnterprisesAPOG

$3.2M+216%

Mission Produce, Inc.AVO

$1.68M+42.6%

VestisVSTS

$4.2M—

HTF

Heartflow, Inc. Common StockHTFL

$912K+15,100%

Taboola.com Ltd.TBLA

$617K-67.4%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+28.6%

Enterprise value$885.15M+28.3%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's capital investments accrued but not yet paid?: Replimune Group (REPL) reported capital investments accrued but not yet paid of -$177K in Q4 2025.
How has Replimune Group's capital investments accrued but not yet paid changed year-over-year?: Replimune Group's capital investments accrued but not yet paid decreased by 193.7% year-over-year, from $189K to -$177K.